This Phase 3 Trial has Shown Improved Overall Survival - Toxicity Profile has been stable with prolonged exposure to drugs - 101931

Spotlight
Video

This Phase 3 Trial has Shown Improved Overall Survival - Toxicity Profile has been stable with prolonged exposure to drugs

ASHReport has 256 videos Subscribe Here

Loading........
Description: Keith Stewart, MD from Mayo Clinic Division of Hematology and Oncology discusses this phase 3 trial has shown improved overall survival and toxicity profile has been stable with prolonged exposure to drugs at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/23/18
Added : 9 months ago
Category : Multiple Myeloma